Sometimes in science, "Eureka!" moments happen with surprisingly little effort. Sometimes they take years or decades to emerge. Such was the case with Brian Kraemer's research team and their recent study of the protein tau ...
Feb 6, 2023
0
47
Ph.D. student Pradeepa Pushparaj, in Gunilla Karlsson Hedestams group at the Department of Microbiology, Tumor and Cell Biology, is the first author of a study recently published in Immunity.
Feb 3, 2023
0
3
A monoclonal antibody treatment was found to be safe, well tolerated, and effective in protecting against malaria in a small group of healthy volunteers who were exposed to malaria in a challenge study, according to new research ...
Jan 27, 2023
0
23
Interleukin (IL)-15 is a cytokine with different modes of action, and a new article describes why it is important to selectively target the mode of action of the cytokine rather than IL-15 itself to inhibit its activity. ...
Jan 23, 2023
0
1
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
Jan 13, 2023
0
21
Researchers at Vanderbilt University Medical Center have developed a new investigational drug that can block inflammatory signaling in a preclinical model of atopic dermatitis—eczema.
Jan 12, 2023
0
10
A new USC Leonard Davis School of Gerontology study challenges existing ideas of how buildup of a protein called amyloid beta (Aβ) in the brain is related to Alzheimer's disease.
Jan 6, 2023
0
76
Millions of Americans don't have easy access to facilities that dispense oral antiviral treatments for COVID-19, according to a new Yale study. In some parts of the country, researchers found, people have to travel 30 minutes ...
Jan 3, 2023
0
41
In February 2022, the UK government abandoned its remaining pandemic restrictions in favor of "living with COVID". This approach relies largely on vaccines protecting people from severe disease.
Dec 21, 2022
0
3
Researchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by monoclonal antibodies used to treat several cancers.
Dec 20, 2022
0
6
